Additional information
| Active substance | Rivaroxaban |
|---|---|
| Acne | No |
| Water Retention | No |
| HBR | No |
| Hepatotoxicity | No |
| Aromatization | No |
| Lab Test | Anti-factor Xa activity can indirectly measure its effect but is not routinely monitored |
| Also known as | BAY 59-7939 |
| WAREHOUSE | International Warehouse 2 |
| Blood pressure | No significant effect on blood pressure |
| Trade name | Xarelto |
| Storage conditions | Store at 15В°C to 30В°C (59В°F to 86В°F) in a dry place |
| Chemical name | Rivaroxaban |
| Formula | C19H18ClN3O5S |
| Substance class | Anticoagulant |
| Main action | Inhibits thrombin formation by directly targeting Factor Xa |
| Half-life | 5 to 9 hours in healthy individuals, up to 11 to 13 hours in the elderly |
| Dosage (medical) | 10 mg, 15 mg, or 20 mg tablets once daily, depending on the condition being treated |
| Dosage (sports) | N/A |
| Effects | Reduces the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation, treats deep vein thrombosis and pulmonary embolism, prevents blood clots in certain patients |
| Side effects | Bleeding, anemia, liver enzyme changes, dizziness, headache, rash |
| Use in sports | Not typically used in sports |
| Manufacturer | Bayer |
Seretide Disckus (Advair) 500 mcg Glaxosmithkline
Avory Pharma Dianabol 10mg 100 Kapsel
Balkan Pharma Danabol 10 mg 100 Tabletten
Fostimon (Merional) 150 IU HMG IBSA 

Reviews
There are no reviews yet.